Johnson Jianzhong Liu
· University-wide researcher directory · University of New South Wales
Quick answer: Johnson Jianzhong Liu is faculty at University of New South Wales. Johnson Jianzhong Liu shows an active PhD hiring signal as of 2026-09-17.
⭐ We have current research projects for PhD, Masters, Honours and ILP students on the topics of targeting Wnt signalling and drug transporters in cancer therapy.
Research interests
Research Interests:
The broad interest of the lab is concerning cancer pharmacology, experimental therapeutics, targeted cancer therapy, pharmacokinetics, drug transport, chemotherapy-induced neuropathy and cancer risk-related genetic polymorphisms. In particular, we have been involving in the preclinical development of anticancer agents, including small molecules targeting Wnt signalling, copper chelators, platinum/gold/silver-based complexes, vascular-disrupting flavonoids and mulberry fruit extracts using a variety of in vitro and in vivo approaches. We are among the first to identify the links of copper transporters and organic cation transporters with chemotherapy-induced neurotoxicity, and lung cancer risk related genetic polymorphisms in Chinese Han population. We have current research projects for PhD, Masters, Honours and ILP students on the topics of targeting Wnt signalling and drug transporters in cancer therapy.
Membership:
- Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists
- Australasian Clinical Trials Alliance
- American Association for Cancer Research
The broad interest of the lab is concerning cancer pharmacology, experimental therapeutics, targeted cancer therapy, pharmacokinetics, drug transport, chemotherapy-induced neuropathy and cancer risk-related genetic polymorphisms. In particular, we have been involving in the preclinical development of anticancer agents, including small molecules targeting Wnt signalling, copper chelators, platinum/gold/silver-based complexes, vascular-disrupting flavonoids and mulberry fruit extracts using a variety of in vitro and in vivo approaches. We are among the first to identify the links of copper transporters and organic cation transporters with chemotherapy-induced neurotoxicity, and lung cancer risk related genetic polymorphisms in Chinese Han population. We have current research projects for PhD, Masters, Honours and ILP students on the topics of targeting Wnt signalling and drug transporters in cancer therapy.
Frequently asked questions
Is Johnson Jianzhong Liu hiring PhD students at University of New South Wales?
Yes. As of 2026-09-17, Johnson Jianzhong Liu's faculty page shows a PhD hiring signal: We have current research projects for PhD, Masters, Honours and ILP students on the topics of targeting Wnt signalling and drug transporters in cancer therapy..
What does Johnson Jianzhong Liu research?
Research Interests:
The broad interest of the lab is concerning cancer pharmacology, experimental therapeutics, targeted cancer therapy, pharmacokinetics, drug transport, chemotherapy-induced neuropathy and cancer risk-related genetic polymorphisms. In particular, we have been involving in the prec
Data last updated: 2026-09-17 · Source: phd-match.com faculty database.
Is Johnson Jianzhong Liu a match for your research?
Upload your CV and get matched to professors who fit — with hiring signals.
Start matching